Sarepta Therapeutics
SRPT
#4393
Rank
โ‚น212.51 B
Marketcap
โ‚น2,028
Share price
3.55%
Change (1 day)
-81.14%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

EPS for Sarepta Therapeutics (SRPT)

EPS in 2025 (TTM): -โ‚น239.23

According to Sarepta Therapeutics 's latest financial reports the company's current EPS (TTM) is -โ‚น249.02. In 2024 the company made an earnings per share (EPS) of โ‚น222.66.

EPS history for Sarepta Therapeutics from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น239.23-207.44%
2024โ‚น222.66
2018-โ‚น492.59603.9%
2017-โ‚น69.98-85.9%
2016-โ‚น496.225.2%
2015-โ‚น471.6853.1%
2014-โ‚น308.09-0%
2013-โ‚น308.09

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
โ‚น592.56-337.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น192.67-177.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
-โ‚น379.89 52.55%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น4.54-98.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น8.18-103.28%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
โ‚น873.39-450.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Insmed
INSM
-โ‚น562.57 125.91%๐Ÿ‡บ๐Ÿ‡ธ USA